Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-28

Clinical Trial Update: Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing insulin degludec with insulin glargine in subjects with Type 1 diabetes mellitus to assess safety and pharmacokinetics/pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED